BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18039859)

  • 1. Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells.
    Reineke EL; Lam M; Liu Q; Liu Y; Stanya KJ; Chang KS; Means AR; Kao HY
    Mol Cell Biol; 2008 Feb; 28(3):997-1006. PubMed ID: 18039859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogen-activated protein kinase extracellular signal-regulated kinase 2 phosphorylates and promotes Pin1 protein-dependent promyelocytic leukemia protein turnover.
    Lim JH; Liu Y; Reineke E; Kao HY
    J Biol Chem; 2011 Dec; 286(52):44403-11. PubMed ID: 22033920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCP phosphatases suppress renal cell carcinoma by stabilizing PML and inhibiting mTOR/HIF signaling.
    Lin YC; Lu LT; Chen HY; Duan X; Lin X; Feng XH; Tang MJ; Chen RH
    Cancer Res; 2014 Dec; 74(23):6935-46. PubMed ID: 25293974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promyelocytic leukemia protein controls cell migration in response to hydrogen peroxide and insulin-like growth factor-1.
    Reineke EL; Liu Y; Kao HY
    J Biol Chem; 2010 Mar; 285(13):9485-9492. PubMed ID: 20100838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx.
    Ryo A; Hirai A; Nishi M; Liou YC; Perrem K; Lin SC; Hirano H; Lee SW; Aoki I
    J Biol Chem; 2007 Dec; 282(50):36671-81. PubMed ID: 17938171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA.
    Rabellino A; Carter B; Konstantinidou G; Wu SY; Rimessi A; Byers LA; Heymach JV; Girard L; Chiang CM; Teruya-Feldstein J; Scaglioni PP
    Cancer Res; 2012 May; 72(9):2275-84. PubMed ID: 22406621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation.
    Liao Y; Wei Y; Zhou X; Yang JY; Dai C; Chen YJ; Agarwal NK; Sarbassov D; Shi D; Yu D; Hung MC
    Oncogene; 2009 Jul; 28(26):2436-45. PubMed ID: 19448664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Destabilization of KLF10, a tumor suppressor, relies on thr93 phosphorylation and isomerase association.
    Hwang YC; Yang CH; Lin CH; Ch'ang HJ; Chang VHS; Yu WCY
    Biochim Biophys Acta; 2013 Dec; 1833(12):3035-3045. PubMed ID: 23994618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear Phosphoproteome Reveals Prolyl Isomerase PIN1 as a Modulator of Oncogene-Induced Senescence.
    Mohallem R; Aryal UK
    Mol Cell Proteomics; 2024 Feb; 23(2):100715. PubMed ID: 38216124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β1-PML SUMOylation-peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1) form a positive feedback loop to regulate cardiac fibrosis.
    Wu D; Huang D; Li LL; Ni P; Li XX; Wang B; Han YN; Shao XQ; Zhao D; Chu WF; Li BY
    J Cell Physiol; 2019 May; 234(5):6263-6273. PubMed ID: 30246389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
    Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
    Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer.
    Nicole Tsang YH; Wu XW; Lim JS; Wee Ong C; Salto-Tellez M; Ito K; Ito Y; Chen LF
    Oncogene; 2013 Mar; 32(12):1488-96. PubMed ID: 22580604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.
    Lam PB; Burga LN; Wu BP; Hofstatter EW; Lu KP; Wulf GM
    Mol Cancer; 2008 Dec; 7():91. PubMed ID: 19077306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α.
    Rajbhandari P; Ozers MS; Solodin NM; Warren CL; Alarid ET
    J Biol Chem; 2015 May; 290(22):13749-62. PubMed ID: 25866209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding and regulation of the transcription factor NFAT by the peptidyl prolyl cis-trans isomerase Pin1.
    Liu W; Youn HD; Zhou XZ; Lu KP; Liu JO
    FEBS Lett; 2001 May; 496(2-3):105-8. PubMed ID: 11356192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function.
    Lee TH; Chen CH; Suizu F; Huang P; Schiene-Fischer C; Daum S; Zhang YJ; Goate A; Chen RH; Zhou XZ; Lu KP
    Mol Cell; 2011 Apr; 42(2):147-59. PubMed ID: 21497122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer.
    Khanal P; Kim G; Lim SC; Yun HJ; Lee KY; Choi HK; Choi HS
    FASEB J; 2013 Nov; 27(11):4606-18. PubMed ID: 23934277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pin1 down-regulates transforming growth factor-beta (TGF-beta) signaling by inducing degradation of Smad proteins.
    Nakano A; Koinuma D; Miyazawa K; Uchida T; Saitoh M; Kawabata M; Hanai J; Akiyama H; Abe M; Miyazono K; Matsumoto T; Imamura T
    J Biol Chem; 2009 Mar; 284(10):6109-15. PubMed ID: 19122240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha.
    Gianni' M; Boldetti A; Guarnaccia V; Rambaldi A; Parrella E; Raska I; Rochette-Egly C; Del Sal G; Rustighi A; Terao M; Garattini E
    Cancer Res; 2009 Feb; 69(3):1016-26. PubMed ID: 19155306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer.
    Saeidi S; Kim SJ; Guillen-Quispe YN; Jagadeesh ASV; Han HJ; Kim SH; Zhong X; Piao JY; Kim SJ; Jeong J; Shin YJ; Cha YJ; Lee HB; Han W; Min SH; Tian W; Kitamura H; Surh YJ
    FASEB J; 2022 Jan; 36(1):e22068. PubMed ID: 34918396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.